Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan

BACKGROUND AND AIM: Proton pump inhibitors and vonoprazan (a potassium-competitive acid blocker) are recommended as first-line treatments for gastroesophageal reflux disease (GERD). However, few reports have investigated the onset of action of these agents for GERD symptom relief. The present study...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakurai, Kouichi, Suda, Hiroko, Fujie, Satomi, Takeichi, Takayuki, Okuda, Ayako, Murao, Tetsuya, Hasuda, Kiwamu, Hirano, Masahiro, Ito, Kiyoharu, Tsuruta, Katsuie, Hattori, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440932/
https://www.ncbi.nlm.nih.gov/pubmed/30415407
http://dx.doi.org/10.1007/s10620-018-5365-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440932/
https://www.ncbi.nlm.nih.gov/pubmed/30415407
http://dx.doi.org/10.1007/s10620-018-5365-0

Ejemplares similares